Summary
A genital herpesvirus type 2 infection in guinea pigs has been used to evaluate the inhibitory effect of phosphonoformate on the infection. An early topical treatment prevented the appearance of vesicles and histopathological changes and no virus could be recovered. When treatment, either topical or both systemic and topical, was delayed to 24 hours post infection no therapeutic effect was observed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adams, H. G., Benson, E. A., Alexander, E. R., Vontver, L. A., Remington, M. A., Holmes, K. K.: Genital herpetic infection in men and women: clinical course and effect of topical application of adenine arabinoside. In:Merigan, T. C. (ed.), Antivirals with clinical potential, 151–159. University of Chicago Press 1976.
Alenius, S., Dinter, Z., Öberg, B.: Therapeutic effect of trisodiumphosphonoformate on cutaneous herpesvirus infection in guinea pigs. Antimicrobial Agents and Chemotherapy14, 408–413 (1978).
Alenius, S., Öberg, B.: Comparison of the therapeutic effects of five antiviral agents on cutaneous herpesvirus infection in guinea pigs. Arch. Virol.58, 277–288 (1978).
Alford, C. A., Whitley, R. J.: Treatment of infections due to herpesvirus in humans: A critical review of the state of the art. In:Merigan, T. C. (ed.), Antivirals with clinical potential, 101–108. University of Chicago Press 1976.
Aurelian, L., Royston, J., Davis, H. J.: Antibody to genital herpes simplex virus: association with cervical atypia and carcinomain situ. J. nat. Cancer Inst.45, 455–464 (1970).
Ejercito, P. M., Kieff, E. D., Roizman, B.: Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J. gen. Virol.2, 357–364 (1968).
Helgstrand, E., Eriksson, B., Johansson, N. G., Lannerö, B., Larsson, A., Misiorny, A., Noren, J. O., Sjöberg, B., Stenberg, K., Stening, G., Stridh, S., Öberg, B., Alenius, S., Philipson, L.: Trisodium phosphonoformate, a new antiviral compound. Science201, 819–821 (1978).
Kern, E. R., Overall, J. C., Jr., Glasgow, L. A., Reno, J. M., Boezi, J. A.: Activity of phosphonoformate against experimental herpes simplex virus infections. Abstracts of the Annual Meetings of the American Society for Microbiology, 1978, p. 221, abstract S. 50.
Kern, E. R., Richards, J. T., Overall, J. C., Jr., Glasgow, L. A.: Genital herpesvirus hominis infection in mice. II. Treatment with phosphonoacetic acid, adenine arabinoside and adenine arabinoside 5′-monophosphate. J. inf. Dis.135, 557–567 (1977).
Krinke, G., Žák, F., Lukáš, B., Wiesendanger, W., Schmidt-Ruppin, K. H.: Herpes genitalis in guinea pigs. II. Morphological studies in female guinea pigs infected with herpesvirus hominis type 2. Arch. Virol.49, 13–24 (1975).
Lukáš, B., Wiesendanger, W., Schmidt-Ruppin, K. H.: Genital herpes in guinea pigs. An experimental model with herpes-virus hominis. Arch. ges. Virusforsch.44, 153–155 (1974).
Lukáš, B., Wiesendanger, W., Schmidt-Ruppin, K. H.: Herpes genitalis in guinea pigs. 1. Kinetic study in infection with herpesvirus hominis type 2. Arch. Virol.49, 1–11 (1975).
Nahmias, A. J., London, W. T., Catalano, L. W., Fucillo, D. A., Sever, J. C., Graham, C.: Genital herpesvirus hominis type 2 infection: An experimental model in Cebus monkeys. Science171, 297–298 (1971).
Nahmias, A. J., Roizman, B.: Infection with herpes simplex viruses 1 and 2 (Third of three parts). N. Engl. J. of Med.289, 781–789 (1973).
Naib, Z. M., Nahmias, A. J., Josey, W. E., Kramer, J. H.: Genital herpetic infection: Association with cervical dysplasia and carcinoma. Cancer23, 940–945 (1969).
Naib, Z. M., Nahmias, A. J., Zaki, S. A.: Relation of cytohistopathology of genital herpesvirus infection to cervical anaplasia. Cancer Res.33, 1452–1463 (1973).
Novak, E. R., Woodruff, J. D.: Gynecologic and obstetric pathology. Philadelphia-London: W. B. Saunders 1967.
Nylén, P.: Beitrag zur Kenntnis der organischen Phosphorverbindungen. Chem. Berichte57 B, 1023–1038 (1924).
Palmer, A. E., London, W. T., Sever, J. L.: Disodium-phosphonoacetate in cream base as a possible topical treatment for skin lesions of herpes simplex virus in Cebus monkeys. Antimicrobial Agents and Chemotherapy12, 510–512 (1977).
Parker, J. D.: A double blind trial of iodoxuridine in recurrent genital herpes. J. Antimicrob. Chemother.3, 131–137 (1977).
Renis, H. E.: Chemotherapy of genital herpes simplex virus type 2 infections of female hamsters. Antimicrob. Ag. Chemoth.11, 701–707 (1977).
Reno, J. M., Lee, L. E., Boezi, J. A.: Inhibition of herpesvirus replication and herpesvirus induced deoxyribonucleic acid polymerase by phosphonoformate. Antimicrob. Ag. Chemother.13, 188–192 (1978).
Scriba, M.: Recurrent genital herpes simplex virus of guinea pigs. Med. Microbiol. Immunol.162, 201–208 (1976).
Underwood, G. E.: Kethoxal for treatment of cutaneous herpes simplex. Proc. Soc. exp. Biol. Med.129, 235–239 (1968).
Underwood, G. E., Nichol, F. E.: Clinical evaluation of kethoxal against cutaneous herpes simplex. Appl. Microbiol.22, 588–592 (1971).
Author information
Authors and Affiliations
Additional information
With 5 Figures
Rights and permissions
About this article
Cite this article
Alenius, S., Nordlinder, H. Effect of trisodium phosphonoformate in genital infection of female guinea pigs with herpes simplex virus type 2. Archives of Virology 60, 197–206 (1979). https://doi.org/10.1007/BF01317491
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01317491